| High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability AK Croker, D Goodale, J Chu, C Postenka, BD Hedley, DA Hess, AL Allan Journal of cellular and molecular medicine 13 (8b), 2236-2252, 2009 | 652 | 2009 |
| The role of human aldehyde dehydrogenase in normal and cancer stem cells I Ma, AL Allan Stem cell reviews and reports 7, 292-306, 2011 | 624 | 2011 |
| Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells AK Croker, AL Allan Breast cancer research and treatment 133, 75-87, 2012 | 382 | 2012 |
| Cancer stem cells: implications for the progression and treatment of metastatic disease AK Croker, AL Allan Journal of cellular and molecular medicine 12 (2), 374-390, 2008 | 381 | 2008 |
| Circulating tumor cell analysis: technical and statistical considerations for application to the clinic AL Allan, M Keeney Journal of oncology 2010 (1), 426218, 2010 | 238 | 2010 |
| Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis AL Allan, SA Vantyghem, AB Tuck, AF Chambers Breast disease 26 (1), 87-98, 2007 | 228 | 2007 |
| Assessment of the validity of nuclear-localized androgen receptor splice variant 7 in circulating tumor cells as a predictive biomarker for castration-resistant prostate cancer HI Scher, RP Graf, NA Schreiber, A Jayaram, E Winquist, B McLaughlin, ... JAMA oncology 4 (9), 1179-1186, 2018 | 227 | 2018 |
| Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial DA Palma, R Olson, S Harrow, RJM Correa, F Schneiders, CJA Haasbeek, ... BMC cancer 19, 1-15, 2019 | 201 | 2019 |
| Molecular mechanisms of breast cancer metastasis to the lung: clinical and experimental perspectives B Medeiros, AL Allan International journal of molecular sciences 20 (9), 2272, 2019 | 191 | 2019 |
| Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer PM McGowan, C Simedrea, EJ Ribot, PJ Foster, D Palmieri, PS Steeg, ... Molecular Cancer Research 9 (7), 834-844, 2011 | 163 | 2011 |
| Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer AL Allan, R George, SA Vantyghem, MW Lee, NC Hodgson, CJ Engel, ... The American journal of pathology 169 (1), 233-246, 2006 | 161 | 2006 |
| Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management AB Tuck, AF Chambers, AL Allan Journal of cellular biochemistry 102 (4), 859-868, 2007 | 160 | 2007 |
| Nanoparticle‐mediated binning and profiling of heterogeneous circulating tumor cell subpopulations RM Mohamadi, JD Besant, A Mepham, B Green, L Mahmoudian, T Gibbs, ... Angewandte Chemie International Edition 54 (1), 139-143, 2015 | 158 | 2015 |
| Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors M Rodriguez-Torres, AL Allan Clinical & experimental metastasis 33, 97-113, 2016 | 157 | 2016 |
| β3 Integrin Expression Increases Breast Carcinoma Cell Responsiveness to the Malignancy-Enhancing Effects of Osteopontin KA Furger, AL Allan, SM Wilson, C Hota, SA Vantyghem, CO Postenka, ... Molecular cancer research 1 (11), 810-819, 2003 | 156 | 2003 |
| Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer SA Sabra, AO Elzoghby, SA Sheweita, M Haroun, MW Helmy, ... European Journal of Pharmaceutics and Biopharmaceutics 128, 156-169, 2018 | 142 | 2018 |
| Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system AC Nichols, LE Lowes, CCT Szeto, J Basmaji, S Dhaliwal, C Chapeskie, ... Head & neck 34 (10), 1440-1444, 2012 | 133 | 2012 |
| Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease I Plante, MKG Stewart, K Barr, AL Allan, DW Laird Oncogene 30 (14), 1681-1692, 2011 | 125 | 2011 |
| The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression BD Hedley, AL Allan, A Xenocostas Clinical cancer research 17 (20), 6373-6380, 2011 | 124 | 2011 |
| Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry AL Allan, SA Vantyghem, AB Tuck, AF Chambers, IH Chin‐Yee, ... Cytometry Part A: the journal of the International Society for Analytical …, 2005 | 110 | 2005 |
Ann F. ChambersProfessor Emerita, Oncology, Medical Biophysics, Pathology & Lab. Med., Western University在 uwo.ca 的电子邮件经过验证
